|
시장보고서
상품코드
2016668
아페레시스 장비 시장 규모, 점유율, 동향 및 예측 : 제품, 용도, 시술, 기술, 최종사용자, 지역별(2026-2034년)Apheresis Equipment Market Size, Share, Trends and Forecast by Product, Application, Procedure, Technology, End User, and Region, 2026-2034 |
||||||
2025년의 세계 아페레시스 장비 시장 규모는 30억 달러로 평가되었습니다. 향후에 대해 IMARC Group은 2026-2034년에 CAGR 7.33%로 추이하며, 2034년까지 시장 규모가 59억 달러에 달할 것으로 예측하고 있습니다. 현재 북미가 시장을 주도하고 있으며, 2025년 시장 점유율은 35.0%를 차지하고 있습니다. 전 세계 인구의 자가면역질환 및 만성질환 발병률 증가가 시장 성장을 촉진하고 있습니다. 또한 시술의 안전성, 효율성, 정확성을 높이는 지속적인 기술 발전이 시장 성장을 지원하고 있습니다. 또한 혈액 성분의 채취 및 치료 절차의 개선으로 인해 아페레시스 장비의 시장 점유율이 확대되고 있습니다.
원심분리법 또는 막여과법을 이용하여 세포, 혈장, 혈소판, 백혈구 등 특정 성분을 혈액에서 제거하는 데 사용되는 아페레시스 장비. 그 후, 나머지 혈액 성분은 기증자 또는 환자의 혈류로 되돌아갑니다. 이 기술은 혈액은행 및 다양한 질병 치료에 적용되고 있습니다. 최근에는 최신 원심분리장치의 도입으로 자동분리, 유체유체역학 등 첨단 기능이 개발되어 혈소판 및 적혈구(RBC) 농축액 채취가 가능해졌습니다.
신종 코로나바이러스 감염증(COVID-19)의 확산과 효과적인 백신 및 치료제 부족으로 회복기 혈장치료가 중증 환자 치료 수단으로 주목받고 있습니다. 이 치료법은 아페레시스 장비를 이용해 완전히 회복된 환자로부터 회복기 혈장(CP)을 채취해 항체 공급원으로 활동성 질환 환자에게 수혈하는 치료법입니다. 이 외에도 만성질환 및 신경질환의 유병률 증가와 헌혈자 수 증가도 시장 성장에 기여하고 있습니다. 또한 유리한 상환 정책과 의료 인프라의 개선이 결합되어 전 세계에서 아페레시스 장비의 판매를 주도하고 있습니다. 자동 인터페이스 시스템, 화면 탐색, 그래픽 사용자 인터페이스(GUI) 디스플레이를 갖춘 고급 모델의 도입, 연구개발(R&D) 활동에 대한 투자 확대 등 다른 요인들도 향후 수년간 시장에 긍정적인 전망을 가져다 줄 것으로 예상됩니다. 전망하고 있습니다.
이 보고서에서 답변하는 주요 질문:
- 지금까지의 세계 아페레시스 장비 시장의 동향은 어떠했으며, 향후 수년간 어떻게 추이하는가?
- COVID-19가 글로벌 아페레시스 장비 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은 어디인가?
- 제품별로 보면 시장 내역은?
- 용도별 시장 현황은?
- 시술별 시장 현황은?
- 기술별 시장 현황은?
- 최종사용자별 시장 분석은 어떻게 이루어지고 있는가?
- 이 산업의 밸류체인에서 각 단계는 어떤 역할을 하는가?
- 이 산업의 주요 촉진요인과 과제는 무엇인가?
- 세계의 아페레시스 장비 시장의 구조는 무엇이며, 주요 기업은 어디인가?
- 업계내 경쟁은 어느 정도 치열한가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 아페레시스 장비 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 시술별
제9장 시장 내역 : 기술별
제10장 시장 내역 : 최종사용자별
제11장 시장 내역 : 지역별
제12장 SWOT 분석
제13장 밸류체인 분석
제14장 Porter's Five Forces 분석
제15장 가격 분석
제16장 경쟁 구도
KSAThe global apheresis equipment market size was valued at USD 3.0 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 5.9 Billion by 2034, exhibiting a CAGR of 7.33% from 2026-2034. North America currently dominates the market, holding a market share of 35.0% in 2025. The increased incidence of autoimmune and chronic diseases among global populations is impelling the market growth. Moreover, continuous technological advancements that enhance procedure safety, efficiency, and accuracy are supporting the market growth. Additionally, the enhancements in blood component collection and in therapeutic procedures are expanding the apheresis equipment market share.
Apheresis equipment is used to remove specific constituents from the blood, such as the cells, plasma, platelets or leukocytes, using either centrifugal or membrane filtration methods. The remaining blood components are then reintroduced into the bloodstream of the donor or patient. It finds application in blood banks and the treatment of various medical conditions. In recent years, the introduction of modern apheresis equipment has led to the development of advanced features, such as auto elutriation and fluid flow dynamics, and has enabled the collection of platelets or red blood cells (RBCs) concentrates.
Due to the spread of the coronavirus disease (COVID-19) and lack of an effective vaccine or treatment, convalescent plasma therapy is emerging as a measure for treating critically ill patients. Apheresis equipment is utilized in this therapy to collect convalescent plasma (CP) from fully recovered patients and transfuse it to active patients as a source of antibodies. Besides this, the growing prevalence of chronic diseases and neurological disorders, along with the rising number of blood donors, is also contributing to the market growth. Moreover, favorable reimbursement policies, coupled with improving healthcare infrastructure, are also driving the sales of apheresis equipment around the world. Other factors, such as the introduction of advanced variants with automated interface systems, screen navigation and graphical user interface displays, along with the increasing investments in research and development (R&D) activities, are expected to create a positive outlook for the market in the coming years.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global apheresis equipment market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on product, application, procedure, technology and end user.
Breakup by Product:
- Disposable Apheresis Kits
- Apheresis Machine
Breakup by Application:
- Blood Collection
- Treatment
- Neurology
- Hematology
- Renal Diseases
- Others
Breakup by Procedure:
- Plasmapherasis
- Plateletpherasis
- Erythrocytapheresis
- Leukapheresis
- Photopheresis
- Others
Breakup by Technology:
- Membrane Filtration
- Centrifugation
Breakup by End User:
- Blood Collection Centers
- Hospitals and Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Corporation, B. Braun Melsungen Aktiengesellschaft, Baxter International Inc., Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA), Haemonetics Corporation, Hemacare Corporation (Charles River Laboratories Inc.), Kaneka Corporation, Kawasumi Laboratories Inc., Medica SpA, Nikkiso Co Ltd. and Terumo BCT Inc. (Terumo Corporation).
Key Questions Answered in This Report:
- How has the global apheresis equipment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global apheresis equipment market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the procedure?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global apheresis equipment market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Apheresis Equipment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Disposable Apheresis Kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Apheresis Machine
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Application
- 7.1 Blood Collection
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Treatment
- 7.2.1 Market Trends
- 7.2.2 Major Types
- 7.2.2.1 Neurology
- 7.2.2.2 Hematology
- 7.2.2.3 Renal Diseases
- 7.2.2.4 Others
- 7.2.3 Market Forecast
8 Market Breakup by Procedure
- 8.1 Plasmapherasis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Plateletpherasis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Erythrocytapheresis
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Leukapheresis
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Photopheresis
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by Technology
- 9.1 Membrane Filtration
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Centrifugation
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by End User
- 10.1 Blood Collection Centers
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Hospitals and Clinics
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Asahi Kasei Corporation
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 B. Braun Melsungen Aktiengesellschaft
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 SWOT Analysis
- 16.3.3 Baxter International Inc.
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.3.4 SWOT Analysis
- 16.3.4 Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA)
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 SWOT Analysis
- 16.3.5 Haemonetics Corporation
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 Hemacare Corporation (Charles River Laboratories, Inc.)
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.7 Kaneka Corporation
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.7.4 SWOT Analysis
- 16.3.8 Kawasumi Laboratories Inc.
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.9 Medica SpA
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.10 Nikkiso Co Ltd.
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.10.4 SWOT Analysis
- 16.3.11 Terumo BCT Inc. (Terumo Corporation)
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 SWOT Analysis
- 16.3.1 Asahi Kasei Corporation
